Herrlinger U - Search Results

1

Successful radiopeptide targeting of metastatic anaplastic meningioma: case report.

Sabet A, Ahmadzadehfar H, Herrlinger U, Wilinek W, Biersack HJ, Ezziddin S. Sabet A, et al. Among authors: herrlinger u. Radiat Oncol. 2011 Aug 12;6:94. doi: 10.1186/1748-717X-6-94. Radiat Oncol. 2011. PMID: 21835043 Free PMC article.

2

FLAIR-only progression in bevacizumab-treated relapsing glioblastoma does not predict short survival.

Schaub C, Greschus S, Seifert M, Waha A, Blasius E, Rasch K, Landwehr C, Mack F, Schäfer N, Stuplich M, Kebir S, Vilz B, Scheffler B, Boström J, Simon M, Urbach H, Glas M, Herrlinger U. Schaub C, et al. Among authors: herrlinger u. Oncology. 2013;85(3):191-5. doi: 10.1159/000354692. Epub 2013 Sep 5. Oncology. 2013. PMID: 24008924

3

Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.

Boström JP, Seifert M, Greschus S, Schäfer N, Glas M, Lammering G, Herrlinger U. Boström JP, et al. Among authors: herrlinger u. Strahlenther Onkol. 2014 Apr;190(4):416-21. doi: 10.1007/s00066-013-0505-0. Epub 2014 Jan 17. Strahlenther Onkol. 2014. PMID: 24429478

4

Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series.

Glas M, Koch H, Hirschmann B, Jauch T, Steinbrecher A, Herrlinger U, Bogdahn U, Hau P. Glas M, et al. Among authors: herrlinger u. Oncology. 2007;72(5-6):302-7. doi: 10.1159/000113052. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198491

5

Procarbazine and CCNU as initial treatment in gliomatosis cerebri.

Glas M, Rasch K, Wiewrodt D, Weller M, Herrlinger U. Glas M, et al. Among authors: herrlinger u. Oncology. 2008;75(3-4):182-5. doi: 10.1159/000163057. Epub 2008 Oct 8. Oncology. 2008. PMID: 18841032 Free article.

6

Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.

Glas M, Hundsberger T, Stuplich M, Wiewrodt D, Kurzwelly D, Nguyen-Huu B, Rasch K, Herrlinger U. Glas M, et al. Among authors: herrlinger u. Oncology. 2009;76(3):184-9. doi: 10.1159/000201943. Epub 2009 Feb 13. Oncology. 2009. PMID: 19218824

7

Bevacizumab-induced regression of anaplastic meningioma.

Puchner MJA, Hans VH, Harati A, Lohmann F, Glas M, Herrlinger U. Puchner MJA, et al. Among authors: herrlinger u. Ann Oncol. 2010 Dec;21(12):2445-2446. doi: 10.1093/annonc/mdq634. Epub 2010 Nov 1. Ann Oncol. 2010. PMID: 21041375 Free article. No abstract available.

8

Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.

Schäfer N, Tichy J, Thanendrarajan S, Kim Y, Stuplich M, Mack F, Rieger J, Simon M, Scheffler B, Boström J, Steinbach JP, Herrlinger U, Glas M. Schäfer N, et al. Among authors: herrlinger u. Oncology. 2011;80(5-6):330-2. doi: 10.1159/000330358. Epub 2011 Jul 27. Oncology. 2011. PMID: 21791942

9

Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma.

Mack F, Schäfer N, Kebir S, Stuplich M, Schaub C, Niessen M, Scheffler B, Herrlinger U, Glas M. Mack F, et al. Among authors: herrlinger u. Oncology. 2014;86(5-6):369-72. doi: 10.1159/000360295. Epub 2014 Jun 18. Oncology. 2014. PMID: 24942787

10

Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.

Kebir S, Fimmers R, Galldiks N, Schäfer N, Mack F, Schaub C, Stuplich M, Niessen M, Tzaridis T, Simon M, Stoffels G, Langen KJ, Scheffler B, Glas M, Herrlinger U. Kebir S, et al. Among authors: herrlinger u. Clin Cancer Res. 2016 May 1;22(9):2190-6. doi: 10.1158/1078-0432.CCR-15-1334. Epub 2015 Dec 16. Clin Cancer Res. 2016. PMID: 26673798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters